Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design

INTRODUCTION: Therapeutic advances have markedly increased life expectancy for those with cystic fibrosis (CF), resulting in a median predicted survival over 50 years. Consequently, people with CF (pwCF) are living through their reproductive years and the rate of pregnancy is rapidly rising. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Raksha, Magaret, Amalia, Vu, Phuong T, VanDalfsen, Jill M, Keller, Ashley, Wilson, Alexandra, Putman, Melissa S, Mayer-Hamblett, Nicole, Esther, Charles R, Taylor-Cousar, Jennifer L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cystic Fibrosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204448/
https://www.ncbi.nlm.nih.gov/pubmed/35710144
http://dx.doi.org/10.1136/bmjresp-2022-001289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204448/
https://www.ncbi.nlm.nih.gov/pubmed/35710144
http://dx.doi.org/10.1136/bmjresp-2022-001289

Ejemplares similares